Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases

OBJECTIVE: To compare the efficacy and adverse effects of paclitaxel-etoposide-carboplatin/cisplatin (TEP/TCE) regimen with those of etoposide-carboplatin/cisplatin (EP/CE) regimen as first-line treatment for combined small-cell lung cancer (CSCLC). METHODS: A retrospective study was conducted on 62...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Biol Med
Autors principals: Li, Yue-Ya, Zhou, Chan, Yang, Deng-Xia, Wang, Jing, Liu, Zhu-Jun, Wang, Xin-Yue, Li, Kai
Format: Artigo
Idioma:Inglês
Publicat: Chinese Anti-Cancer Association 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4493380/
https://ncbi.nlm.nih.gov/pubmed/26175927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7497/j.issn.2095-3941.2015.0012
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars